Role of lamin A/C on dendritic cell function in antiviral immunity
Dendritic cells (DCs) play a crucial role in orchestrating immune responses, particularly in promoting IFNγ-producing-CD8 cytotoxic T lymphocytes (CTLs) and IFNγ-producing-CD4 T helper 1 (Th1) cells, which are essential for defending against viral infections. Additionally, the nuclear envelope protein lamin A/C has been implicated in T cell immunity. Nevertheless, the intricate interplay between innate and adaptive immunity in response to viral infections, particularly the role of lamin A/C in DC functions within this context, remains poorly understood. In this study, we demonstrate that mice lacking lamin A/C in myeloid LysM promoter-expressing cells exhibit a reduced capacity to induce Th1 and CD8 CTL responses, leading to impaired clearance of acute primary Vaccinia virus (VACV) infection. Remarkably, in vitro-generated granulocyte macrophage colony-stimulating factor bone marrow-derived DCs (GM-CSF BMDCs) show high levels of lamin A/C. Lamin A/C absence on GM-CSF BMDCs does not affect the expression of costimulatory molecules on the cell membrane but it reduces the cellular ability to form immunological synapses with naïve CD4 T cells. Lamin A/C deletion induces alterations in NFκB nuclear localization, thereby influencing NF-κB-dependent transcription. Furthermore, lamin A/C ablation modifies the gene accessibility of BMDCs, predisposing these cells to mount a less effective antiviral response upon TLR stimulation. This study highlights the critical role of DCs in interacting with CD4 T cells during antiviral responses and proposes some mechanisms through which lamin A/C may modulate DC function via gene accessibility and transcriptional regulation.
Authors
- Virginia Zorita (ORCID: https://orcid.org/0009-0003-1527-9737)
- Francisco Sánchez‐Madrid (ORCID: https://orcid.org/0000-0001-5303-0762)
- Ángela Saéz (ORCID: https://orcid.org/0000-0002-9189-4737)
- Raquel Gómez-Bris (ORCID: https://orcid.org/0000-0001-6665-7732)
- Ana Dopazo (ORCID: https://orcid.org/0000-0002-4910-1684)
- Enrique Vázquez (ORCID: https://orcid.org/0000-0003-1157-2592)
- Ana Quintas (ORCID: https://orcid.org/0000-0003-3721-7580)
- José María González (ORCID: https://orcid.org/0000-0002-1177-869X)
- Beatriz Herrero‐Fernández (ORCID: https://orcid.org/0000-0002-2960-6378)
- Salvador Iborra (ORCID: https://orcid.org/0000-0002-1607-1749)
- Silvia M. Arribas (ORCID: https://orcid.org/0000-0001-7103-6105)
- Marina Ortega-Zapero (ORCID: https://orcid.org/0000-0002-7358-3265)
Institutions
- Universidad Complutense de Madrid (ES)
- Universidad de Alcalá (ES)
- Universidad Francisco de Vitoria (ES)
- Research Institute Hospital 12 de Octubre (ES)
- Centro de Investigación en Red en Enfermedades Cardiovasculares (ES)
- Inmunotek (Spain) (ES)
- Centro de Investigación Biomédica en Red (ES)
- Spanish National Centre for Cardiovascular Research (ES)
- Hospital Universitario de La Princesa (ES)
- Universidad Autónoma de Madrid (ES)
Publication Details
- Journal
- Cellular and Molecular Life Sciences
- Published
- 2024-09-12
- DOI
- https://doi.org/10.1007/s00018-024-05423-9
- Citations
- 1
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.24
Funders
- Comunidad de Madrid
- Universidad Francisco de Vitoria
- Ministerio de Ciencia, Innovación y Universidades
- Ministerio de Economía y Competitividad
- Centro Nacional de Investigaciones Cardiovasculares
- Instituto de Salud Carlos III
- European Regional Development Fund